Her2 Targeting Peptides Screening And Applications In Tumor Imaging And Drug Delivery

Lingling Geng,Zihua Wang,Xiangqian Jia,Qiuju Han,Zhichu Xiang,Dan Li,Xiaoliang Yang,Di Zhang,Xiangli Bu,Weizhi Wang,Zhiyuan Hu,Qiaojun Fang

DOI: https://doi.org/10.7150/thno.14302

IF: 11.6

2016-01-01

Theranostics

Abstract:Herein, computational-aided one-bead-one-compound (OBOC) peptide library design combined with in situ single-bead sequencing microarray methods were successfully applied in screening peptides targeting at human epidermal growth factor receptor-2 (HER2), a biomarker of human breast cancer. As a result, 72 novel peptides clustered into three sequence motifs which are PYL*** NP, YYL*** NP and PPL*** NP were acquired. Particularly one of the peptides, P51, has nanomolar affinity and high specificity for HER2 in ex vivo and in vivo tests. Moreover, doxorubicin (DOX)-loaded liposome nanoparticles were modified with peptide P51 or P25 and demonstrated to improve the targeted delivery against HER2 positive cells. Our study provides an efficient peptide screening method with a combination of techniques and the novel screened peptides with a clear binding site on HER2 can be used as probes for tumor imaging and targeted drug delivery.